Key Takeaways
- • OpenEvidence, a Miami-based AI company, has reached a $12 billion valuation and is nearing an initial public offering, according to the South Florida Business Journal.
- • The South Florida Business Journal reports that the company has one of the highest IPO probabilities among venture-backed life sciences startups in its analysis.
- • South Florida startups raised $900 million in venture capital during the third quarter of 2026, per the publisher's reporting.
- • Regional venture funding is running at a pace that could exceed prior periods, with Miami-area startups having raised $832 million in Q2 2026 alone, according to PitchBook data cited in publisher coverage.
Summary
The South Florida Business Journal reports that Miami-based AI company OpenEvidence is nearing an initial public offering, with the company valued at $12 billion. Reporter Ashley Portero writes that the company has one of the highest IPO probabilities among venture-backed life sciences startups, based on the publication's analysis. The report describes the company as a potential fast-track IPO candidate.
The report is framed against a strong quarter for regional venture capital. South Florida startups secured $900 million during the third quarter of 2026, according to the publisher's coverage. That figure follows a sizable second quarter: PitchBook data cited in separate Business Journals reporting show Miami-area startups attracted $832 million in venture capital in Q2 2026, and nearly $2 billion across the first two quarters of the year. A Miami tech-hub tracker also cited six unicorns in the region, with cumulative funding of $4.13 billion.
The OpenEvidence IPO would be a notable test of the region's emerging AI and life sciences cluster. Publisher summaries note that the company's listing prospects are tied to its venture-backed growth trajectory, though the available reporting does not specify an offering size, exchange, or timeline. Investors tracking the South Florida pipeline should treat the IPO as a near-term prospect rather than a confirmed transaction.
The report is framed against a strong quarter for regional venture capital. South Florida startups secured $900 million during the third quarter of 2026, according to the publisher's coverage. That figure follows a sizable second quarter: PitchBook data cited in separate Business Journals reporting show Miami-area startups attracted $832 million in venture capital in Q2 2026, and nearly $2 billion across the first two quarters of the year. A Miami tech-hub tracker also cited six unicorns in the region, with cumulative funding of $4.13 billion.
The OpenEvidence IPO would be a notable test of the region's emerging AI and life sciences cluster. Publisher summaries note that the company's listing prospects are tied to its venture-backed growth trajectory, though the available reporting does not specify an offering size, exchange, or timeline. Investors tracking the South Florida pipeline should treat the IPO as a near-term prospect rather than a confirmed transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.